Halladay Benjamin - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 14, 2024, Halladay Benjamin's relationship to Esperion Therapeutics, Inc. (ESPR) is Officer (Chief Financial Officer), and currently has 243,936 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Data Source: SEC.
Halladay Benjamin - Insider Non-Derivative Transactions of ESPR Common Stock
Halladay Benjamin - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 15, 2024 Acquisition -- (Common Stock) 170000 0 243936
Mar 15, 2023 Acquisition -- (Common Stock) 9200 0 73936